ATHIRA PHARMA
Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach and positively impact everyone.
ATHIRA PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.athira.com
Total Employee:
51+
Status:
Active
Contact:
(206) 221-8112
Email Addresses:
[email protected]
Total Funding:
233.6 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Google Universal Analytics Microsoft Exchange Online Office 365 Mail Pound Sterling YouTube Japanese Yen Sectigo SSL Sectigo Domain SSL
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aestus Partners
Aestus Partners is a business advisory firm in the field of biotechnology and pharmaceuticals.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
PSNResearch
PSNResearch is a Pharmaceutical Manufacturing Company that specializes in biotechnology, pharmaceutical.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - Athira Pharma
Primer Capital
Primer Capital investment in Convertible Note - Athira Pharma
Avidity Partners
Avidity Partners investment in Series B - Athira Pharma
Viking Global Investors
Viking Global Investors investment in Series B - Athira Pharma
Highline Capital Management
Highline Capital Management investment in Series B - Athira Pharma
Franklin Templeton
Franklin Templeton investment in Series B - Athira Pharma
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Athira Pharma
Richard Kayne
Richard Kayne investment in Series B - Athira Pharma
Suzanne Kayne
Suzanne Kayne investment in Series B - Athira Pharma
Ditch Plains Capital Management LP
Ditch Plains Capital Management LP investment in Series B - Athira Pharma
Key Employee Changes
Official Site Inspections
http://www.athira.com
- Host name: 45.60.22.212
- IP address: 45.60.22.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Athira Pharma"
Athira Pharma
Feb 27, 2025 Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND. November 7, 2024. …See details»
About - Athira Pharma
He also previously served as chairman of the Washington Technology Center at the University of Washington, which is an organization responsible for managing technology transfers …See details»
Athira Pharma - Crunchbase Company Profile & Funding
Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to …See details»
Athira Pharma - Wikipedia
Athira Pharma is a late clinical stage American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021. See details»
Rachel Lenington - Athira Pharma
Joining the company in June 2021, Rachel is leading the clinical development, marketing, communications, and technical operations teams to deliver on the organization’s mission and growth. Prior to joining Athira, Rachel has spent …See details»
Athira
Athira crafts business support solutions to help your organization reach its goals. Our approach is to understand your business’s growth challenges, design and implement tailored solutions, …See details»
Investor Relations | Athira Pharma
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on …See details»
Restoring Lives by Advancing Bold Therapies - athira.com
Athira and does not necessarily represent the official views of the National Institutes of Health. This presentation concerns drug candidates that are under clinical investigation and which …See details»
Athira Pharma Reports Full Year 2024 Financial Results and …
BOTHELL, Wash., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore …See details»
Athira Pharma - Overview, News & Similar companies - ZoomInfo
Apr 15, 2024 Who is Athira Pharma. Athira Pharma Inc., headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to …See details»
Athira Pharma
Mar 4, 2025 Athira Pharma was known as M3 Biotechnology until it underwent a name change on April 11, 2019. Mission Our mission is to provide our customers and partners with a …See details»
Athira Pharma Inc Company Profile - Overview - GlobalData
Athira Pharma Inc (Athira Pharma) is a clinical-stage biopharmaceutical company that focuses on the development of small molecules to restore neuronal health and slow neurodegeneration. …See details»
Athira Pharma - Contacts, Employees, Board Members
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Annual Reports - Athira Pharma
Apr 16, 2021 The Investor Relations website contains information about Athira Pharma's business for stockholders, potential investors, and financial analysts.See details»
Corporate Presentation - Athira Pharma
Information presented in this press release is solely the responsibility of Athira and does not necessarily represent the official views of the National Institutes of Health. This presentation …See details»
News - Athira Pharma
Nov 7, 2024 Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International …See details»
Athira Pharma - Funding, Financials, Valuation & Investors
Athira Pharma is registered under the ticker NASDAQ:ATHA . Their stock opened with $17.00 in its Sep 17, 2020 IPO. Athira Pharma is funded by 26 investors. National Institute on Aging and …See details»
Athira Pharma Announces Formation of Scientific Advisory Board ...
BOTHELL, Wash., June 07, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small …See details»
Athira Urges Shareholders to Support its Director Nominees at …
May 11, 2022 Athira is well capitalized and advantageously positioned to execute key objectives with cash on hand to fund the organization through multiple upcoming clinical milestones, …See details»
Athira Mails Letter to Shareholders Emphasizing the ... - Athira …
May 5, 2022 Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John M. Fluke, Jr. and Grant Pickering – on the WHITE Proxy …See details»